long-term benefits of tirzepatide is redefining obesity & diabetes care. Dual GIP/GLP-1 action → deeper weight loss, stronger metabolic control, and emerging from OSA to cardiometabolic risk. The era multi-pathway incretin therapy has Tirzepatide: Long-Term Use for Diabetes

Semaglutide has been shown to ameliorate hepatic steatosis through weight loss, insulin sensitization, and direct reduction of hepatic fat content (9)

While this is still early-stage research, there are things pharmacy teams can start doing now

Against the emerging virus Several complete SARS-CoV-2 viral genomes were available at the beginning of 2020 [26], and early analysis suggested very little sequence diversity [15]

GLP-1 receptor agonists for weight loss for perimenopausal and postmenopausal women: current evidence

Its primary functions include stimulating insulin release from the pancreas, suppressing glucagon (a hormone that raises blood sugar), slowing gastric emptying, and signalling satiety (fullness) to the brain